While numerous markers, such as PDGFRα, periostin and fibroblast activation protein (FAP) have been reported to identify CAF within the tumor microenvironment [37], SMA is most commonly used to identify those CAF with an ‘activated’ tumor-promoting myofibroblastic phenotype. This evidence concerns the gene PDGFRA and neoplasm.